Cms-10434 #26 Aqm2018-ssd Ad

Centers for Medicare & Medicaid
Services
CMS eXpedited Life Cycle (XLC)

Medicaid and CHIP Program (MACPro)
AQM 2018 – Diabetes Screening for People with
Schizophrenia or Bipolar Disorder Who Are Using
Antipsychotic Medications (SSD-AD) Core
Measure PRA document
Version 1.0
09/05/2018

Document Number: AQM 2018-SSD-AD-PRA-D
Contract Number: HHSM-500-2007-00024I: HHSM-500-T0014

CMS XLC

Table of Contents

Table of Contents
1. (SSD-AD) Core Measure – Screenshots......................................................................... 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
1.10
1.11
1.12

Are you reporting on this measure? ........................................................................ 1
Measurement Specification – Path 1 ...................................................................... 1
Measurement Specification – Path 2 ...................................................................... 1
Data Source ................................................................................................................ 2
Date Range ................................................................................................................. 2
Definition of Population Included in the Measure .................................................. 3
Performance Measure ............................................................................................... 3
Deviations from Measurement Specifications ....................................................... 4
Combined Rate(s) from Multiple Reporting Units ................................................. 4
Additional Notes/Comments on Measure (Optional) ............................................ 4
Optional Measure Stratification – Screenshot 1 .................................................... 5
Optional Measure Stratification – Screenshot 2 .................................................... 5

Appendix A:

Acronyms .................................................................................................... 6

List of Figures
Figure 1: Are you reporting on this measure? ......................................................................... 1
Figure 2: Measurement Specification – 1 ................................................................................. 1
Figure 3: Measurement Specification – 2 ................................................................................. 1
Figure 4: Data Source ................................................................................................................. 2
Figure 5: Date Range .................................................................................................................. 2
Figure 6: Definition of Population Include in the Measure ..................................................... 3
Figure 7: Performance Measure ................................................................................................ 3
Figure 8: Deviations from Measurement Specifications......................................................... 4
Figure 9: Combined Rate(s) from Multiple Reporting Units ................................................... 4
Figure 10: Additional Notes/Comments on Measure (Optional) ........................................... 4
Figure 11: Optional Measure Stratification – 1 ........................................................................ 5
Figure 12: Optional Measure Stratification – 2 ........................................................................ 5

AQM 2018 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-AD) Core
Measure PRA document
Version 1.0
i
09/05/2018

CMS XLC

List of Tables

List of Tables
Table 1: Acronyms ....................................................................................................................... 6

AQM 2018 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-AD) Core
Measure PRA document
Version 1.0
ii
09/05/2018

CMS XLC
(SSD-AD) Core Measure – Screenshots

1. (SSD-AD) Core Measure – Screenshots
1.1

Are you reporting on this measure?

Figure 1: Are you reporting on this measure?

1.2

Measurement Specification – Path 1

Figure 2: Measurement Specification – 1

1.3

Measurement Specification – Path 2

Figure 3: Measurement Specification – 2

AQM 2018 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-AD) Core
Measure PRA document
Version 1.0
1
09/05/2018

CMS XLC
(SSD-AD) Core Measure – Screenshots

1.4

Data Source

Figure 4: Data Source

1.5

Date Range

Figure 5: Date Range

AQM 2018 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-AD) Core
Measure PRA document
Version 1.0
2
09/05/2018

CMS XLC
(SSD-AD) Core Measure – Screenshots

1.6

Definition of Population Included in the Measure

Figure 6: Definition of Population Include in the Measure

1.7

Performance Measure

Figure 7: Performance Measure

AQM 2018 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-AD) Core
Measure PRA document
Version 1.0
3
09/05/2018

CMS XLC
(SSD-AD) Core Measure – Screenshots

1.8

Deviations from Measurement Specifications

Figure 8: Deviations from Measurement Specifications

1.9

Combined Rate(s) from Multiple Reporting Units

Figure 9: Combined Rate(s) from Multiple Reporting Units

1.10 Additional Notes/Comments on Measure (Optional)

Figure 10: Additional Notes/Comments on Measure (Optional)

AQM 2018 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-AD) Core
Measure PRA document
Version 1.0
4
09/05/2018

CMS XLC
(SSD-AD) Core Measure – Screenshots

1.11 Optional Measure Stratification – Screenshot 1
Note: Same N/D/R sets are displayed under each of the stratification categories

Figure 11: Optional Measure Stratification – 1

1.12 Optional Measure Stratification – Screenshot 2

Figure 12: Optional Measure Stratification – 2

AQM 2018 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-AD) Core
Measure PRA document
Version 1.0
5
09/05/2018

CMS XLC
(SSD-AD) Core Measure – Screenshots

Appendix A: Acronyms
Table 1: Acronyms
Acronym

Literal Translation

AQM

Adult Quality Measure

PRA

Paper Reduction Act of 1995

SSD

Diabetes Screening for People with Schizophrenia or Bipolar
Disorder Who Are Using Antipsychotic Medications

AQM 2018 – Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD-AD) Core
Measure PRA document
Version 1.0
6
09/05/2018